PBYI Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 23.70%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $512,704.29

Puma Biotechnology Insider Trading History Chart

Puma Biotechnology Share Price & Price History

^$3.34

▼ -0.18 (-5.11%)

As of 03/13/2025 05:00 PM ET

Days: 30 | 90 | 365

Puma Biotechnology Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/2/2025	Alan H. Auerbach	CEO	Sell	33,841	$3.15	$106,599.15	7,029,674
1/2/2025	Jeffrey Jerome Ludwig	Insider	Sell	9,437	$3.15	$29,726.55	108,951
8/12/2024	Michael Patrick Miller	Director	Sell	23,358	$3.49	$81,519.42	47,000
7/17/2024	Alan H. Auerbach	CEO	Sell	21,920	$3.70	$81,104.00	7,063,515
7/17/2024	Jeffrey Jerome Ludwig	Insider	Sell	2,598	$3.70	$9,612.60	118,388
7/17/2024	Maximo F. Nougues	CFO	Sell	4,156	$3.70	$15,377.20	162,522
7/2/2024	Alan H. Auerbach	CEO	Sell	18,885	$3.27	$61,753.95	7,085,435
7/2/2024	Jeffrey Jerome Ludwig	Insider	Sell	6,051	$3.27	$19,786.77	120,986
7/2/2024	Maximo F. Nougues	CFO	Sell	5,295	$3.27	$17,314.65	166,678
6/13/2024	Troy Edward Wilson	Director	Sell	27,000	$3.33	$89,910.00	350
1/3/2024	Alan H. Auerbach	CEO	Sell	41,396	$4.49	$185,868.04	6,936,947
1/3/2024	Alvin F. Wong	Insider	Sell	7,733	$4.49	$34,721.17	98,214
1/3/2024	Maximo F. Nougues	CFO	Sell	15,682	$4.49	$70,412.18	128,666
11/7/2023	Michael Patrick Miller	Director	Sell	25,000	$2.83	$70,750.00	43,358
7/3/2023	Alan H. Auerbach	CEO	Sell	60,698	$3.31	$200,910.38	6,978,343
7/3/2023	Alvin F. Wong	Insider	Sell	6,938	$3.31	$22,964.78	105,947
7/3/2023	Maximo F. Nougues	CFO	Sell	14,680	$3.31	$48,590.80	144,348
6/13/2023	Troy Edward Wilson	Director	Sell	27,000	$3.45	$93,150.00	350
6/2/2023	Alvin F. Wong	Insider	Sell	269	$3.45	$928.05	112,885
1/3/2023	Alan H. Auerbach	CEO	Sell	27,241	$4.18	$113,867.38	6,852,638
1/3/2023	Alvin F. Wong	Insider	Sell	3,460	$4.18	$14,462.80	54,553
1/3/2023	Maximo F. Nougues	CFO	Sell	10,499	$4.18	$43,885.82	100,427
11/2/2022	Alan H. Auerbach	CEO	Sell	1,242	$2.25	$2,794.50	6,312,949
11/2/2022	Douglas M. Hunt	Insider	Sell	429	$2.25	$965.25	76,004
11/2/2022	Maximo F. Nougues	CFO	Sell	163	$2.25	$366.75	111,085
10/3/2022	Alan H. Auerbach	CEO	Sell	1,260	$2.34	$2,948.40	6,314,191
10/3/2022	Douglas M. Hunt	Insider	Sell	435	$2.34	$1,017.90	76,433
10/3/2022	Maximo F. Nougues	CFO	Sell	165	$2.34	$386.10	111,248
8/9/2022	Michael Patrick Miller	Director	Sell	25,000	$3.55	$88,750.00	54,858
8/2/2022	Alan H. Auerbach	CEO	Sell	1,247	$2.89	$3,603.83	6,316,705
8/2/2022	Douglas M. Hunt	Insider	Sell	429	$2.89	$1,239.81	77,301
8/2/2022	Maximo F. Nougues	CFO	Sell	161	$2.89	$465.29	111,577
7/5/2022	Alan H. Auerbach	CEO	Sell	26,140	$2.63	$68,748.20	6,317,952
7/5/2022	Douglas M. Hunt	Insider	Sell	3,753	$2.63	$9,870.39	77,730
7/5/2022	Maximo F. Nougues	CFO	Sell	5,835	$2.63	$15,346.05	64,625
6/16/2022	Troy Edward Wilson	Director	Sell	27,858	$2.58	$71,873.64	27,350
6/2/2022	Alan H. Auerbach	CEO	Sell	1,200	$1.94	$2,328.00	6,344,092
6/2/2022	Alvin F. Wong	Insider	Sell	587	$1.92	$1,127.04	61,447
6/2/2022	Maximo F. Nougues	CFO	Sell	162	$1.92	$311.04	121,066
5/3/2022	Alan H. Auerbach	CEO	Sell	1,263	$2.32	$2,930.16	6,345,292
5/3/2022	Douglas M. Hunt	Insider	Sell	438	$2.31	$1,011.78	81,900
5/3/2022	Maximo F. Nougues	CFO	Sell	165	$2.34	$386.10	121,228
4/4/2022	Alan H. Auerbach	CEO	Sell	1,198	$3.08	$3,689.84	6,346,555

See Full Table

SEC Filings (Institutional Ownership Changes) for Puma Biotechnology (NASDAQ:PBYI)

61.29% of Puma Biotechnology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Puma Biotechnology Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/20/2025	Mackenzie Financial Corp	78,653	$0.24M	0.0%	N/A	0.160%
2/17/2025	Squarepoint Ops LLC	75,929	$0.23M	0.0%	-23.5%	0.155%
2/17/2025	Two Sigma Investments LP	181,471	$0.55M	0.0%	+266.2%	0.370%
2/17/2025	Two Sigma Advisers LP	196,900	$0.60M	0.0%	+22.3%	0.401%
2/17/2025	State of Wyoming	20,426	$62K	0.0%	-72.0%	0.042%
2/17/2025	ProShare Advisors LLC	11,853	$36K	0.0%	N/A	0.024%
2/17/2025	Nuveen Asset Management LLC	79,101	$0.24M	0.0%	+41.4%	0.161%
2/17/2025	Millennium Management LLC	1,894,126	$5.78M	0.0%	-34.3%	3.858%
2/17/2025	Graham Capital Management L.P.	10,732	$33K	0.0%	N/A	0.022%
2/17/2025	D. E. Shaw & Co. Inc.	222,608	$0.68M	0.0%	+287.9%	0.453%
2/17/2025	Cubist Systematic Strategies LLC	32,615	$99K	0.0%	N/A	0.066%
2/17/2025	Bank of America Corp DE	82,339	$0.25M	0.0%	+103.1%	0.168%
2/17/2025	Bayesian Capital Management LP	17,700	$54K	0.0%	N/A	0.036%
2/17/2025	BNP Paribas Financial Markets	74,301	$0.23M	0.0%	+9.7%	0.151%
2/17/2025	Acorn Capital Advisors LLC	2,450,711	$7.48M	4.1%	N/A	4.992%
2/14/2025	Jane Street Group LLC	22,480	$69K	0.0%	-30.0%	0.046%
2/14/2025	Schonfeld Strategic Advisors LLC	35,300	$0.11M	0.0%	-70.1%	0.072%
2/14/2025	Northern Trust Corp	325,417	$0.99M	0.0%	+2.4%	0.663%
2/14/2025	Oxford Asset Management LLP	23,484	$72K	0.0%	N/A	0.048%
2/14/2025	Price T Rowe Associates Inc. MD	19,083	$59K	0.0%	+42.9%	0.039%
2/14/2025	Eversept Partners LP	996,102	$3.04M	0.3%	-23.0%	2.029%
2/14/2025	Tower Research Capital LLC TRC	10,137	$31K	0.0%	+167.7%	0.021%
2/14/2025	Dimensional Fund Advisors LP	863,760	$2.64M	0.0%	+24.7%	1.760%
2/13/2025	Marshall Wace LLP	85,580	$0.26M	0.0%	N/A	0.174%
2/13/2025	Walleye Capital LLC	38,845	$0.12M	0.0%	N/A	0.079%
2/13/2025	XTX Topco Ltd	59,674	$0.18M	0.0%	+126.2%	0.122%
2/13/2025	Barclays PLC	88,407	$0.27M	0.0%	+13.3%	0.180%
2/13/2025	Kennedy Capital Management LLC	809,375	$2.47M	0.1%	+36.5%	1.649%
2/13/2025	LSV Asset Management	53,400	$0.16M	0.0%	+75.7%	0.109%
2/13/2025	Renaissance Technologies LLC	1,755,513	$5.35M	0.0%	-1.0%	3.576%
2/13/2025	Wells Fargo & Company MN	22,929	$70K	0.0%	+36.5%	0.047%
2/13/2025	Integrated Quantitative Investments LLC	59,866	$0.18M	0.1%	N/A	0.122%
2/12/2025	O Shaughnessy Asset Management LLC	112,571	$0.34M	0.0%	+99.7%	0.229%
2/12/2025	C2C Wealth Management LLC	12,000	$37K	0.0%	N/A	0.024%
2/12/2025	JPMorgan Chase & Co.	136,897	$0.42M	0.0%	+182.3%	0.279%
2/12/2025	WINTON GROUP Ltd	38,241	$0.12M	0.0%	-87.6%	0.078%
2/11/2025	Prudential Financial Inc.	106,285	$0.32M	0.0%	+5.8%	0.217%
2/11/2025	LPL Financial LLC	26,567	$81K	0.0%	+23.6%	0.054%
2/11/2025	Sei Investments Co.	311,661	$0.95M	0.0%	+8.0%	0.635%
2/11/2025	American Century Companies Inc.	948,376	$2.89M	0.0%	+8.4%	1.932%
2/10/2025	Connor Clark & Lunn Investment Management Ltd.	487,368	$1.49M	0.0%	+32.3%	0.993%
2/4/2025	Los Angeles Capital Management LLC	285,679	$0.87M	0.0%	+16.3%	0.582%
2/4/2025	Bank of New York Mellon Corp	331,853	$1.01M	0.0%	+19.5%	0.676%
1/30/2025	Rhumbline Advisers	38,291	$0.12M	0.0%	-17.9%	0.078%
1/23/2025	Gateway Wealth Partners LLC	10,200	$31K	0.0%	N/A	0.021%
1/17/2025	SG Americas Securities LLC	24,668	$75K	0.0%	+83.9%	0.050%
12/26/2024	JPMorgan Chase & Co.	48,493	$0.12M	0.0%	+169.5%	0.099%
11/27/2024	Franklin Resources Inc.	15,967	$41K	0.0%	N/A	0.033%
11/20/2024	Virtu Financial LLC	26,509	$68K	0.0%	N/A	0.054%
11/19/2024	Barclays PLC	78,021	$0.20M	0.0%	+146.5%	0.159%
11/16/2024	Geode Capital Management LLC	917,367	$2.34M	0.0%	-3.4%	1.869%
11/15/2024	Barclays PLC	78,021	$0.20M	0.0%	+146.5%	0.159%
11/15/2024	XTX Topco Ltd	26,384	$67K	0.0%	-45.7%	0.054%
11/15/2024	Jane Street Group LLC	32,129	$82K	0.0%	+103.9%	0.065%
11/15/2024	State Street Corp	601,542	$1.53M	0.0%	+17.0%	1.225%
11/13/2024	BNP Paribas Financial Markets	67,702	$0.17M	0.0%	+2,002.5%	0.138%
11/13/2024	FMR LLC	118,265	$0.30M	0.0%	+27.1%	0.241%
11/13/2024	Advantage Alpha Capital Partners LP	108,129	$0.28M	0.1%	N/A	0.220%
11/13/2024	Dynamic Technology Lab Private Ltd	17,366	$44K	0.0%	N/A	0.035%
11/12/2024	Charles Schwab Investment Management Inc.	117,666	$0.30M	0.0%	-6.8%	0.240%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	368,455	$0.94M	0.0%	+3.9%	0.751%
11/8/2024	Prospera Financial Services Inc	168,885	$0.43M	0.0%	+12.9%	0.344%
11/6/2024	Royce & Associates LP	20,165	$51K	0.0%	+71.8%	0.041%
11/5/2024	Victory Capital Management Inc.	35,097	$89K	0.0%	+111.9%	0.072%
11/5/2024	GSA Capital Partners LLP	49,494	$0.13M	0.0%	-73.9%	0.101%
11/4/2024	Los Angeles Capital Management LLC	245,695	$0.63M	0.0%	N/A	0.501%
10/24/2024	Patriot Financial Group Insurance Agency LLC	19,000	$48K	0.0%	+72.7%	0.039%
10/3/2024	SG Americas Securities LLC	13,416	$34K	0.0%	N/A	0.027%
8/16/2024	Frazier Life Sciences Management L.P.	3,062,558	$9.98M	0.5%	+8.7%	6.349%
8/15/2024	The Manufacturers Life Insurance Company	17,765	$58K	0.0%	N/A	0.036%
8/15/2024	Millennium Management LLC	3,162,533	$10.31M	0.0%	-4.0%	6.448%
8/15/2024	Affinity Asset Advisors LLC	250,000	$0.82M	0.1%	N/A	0.510%
8/14/2024	Squarepoint Ops LLC	71,391	$0.23M	0.0%	+17.7%	0.146%
8/14/2024	Great Point Partners LLC	1,486,544	$4.85M	0.9%	+10.6%	3.082%
8/14/2024	Marshall Wace LLP	200,085	$0.65M	0.0%	-16.1%	0.415%
8/12/2024	XTX Topco Ltd	48,611	$0.16M	0.0%	-10.2%	0.101%
8/12/2024	Marathon Trading Investment Management LLC	14,236	$46K	0.0%	-79.7%	0.030%
8/9/2024	Renaissance Technologies LLC	1,753,013	$5.72M	0.0%	+1.4%	3.634%
8/9/2024	Dimensional Fund Advisors LP	605,977	$1.98M	0.0%	+6.6%	1.256%
8/9/2024	WINTON GROUP Ltd	300,599	$0.98M	0.1%	+59.7%	0.623%
8/8/2024	American Century Companies Inc.	738,902	$2.41M	0.0%	+98.5%	1.532%
8/8/2024	Rice Hall James & Associates LLC	144,792	$0.47M	0.0%	+3.3%	0.300%
8/6/2024	Acadian Asset Management LLC	1,951,208	$6.36M	0.0%	-0.3%	4.045%
8/5/2024	Victory Capital Management Inc.	16,565	$54K	0.0%	N/A	0.034%
8/1/2024	Rhumbline Advisers	50,270	$0.16M	0.0%	+2,309.9%	0.104%
8/1/2024	Ritholtz Wealth Management	33,759	$0.11M	0.0%	-9.6%	0.070%
7/29/2024	Panagora Asset Management Inc.	102,820	$0.34M	0.0%	N/A	0.213%
7/26/2024	Patriot Financial Group Insurance Agency LLC	11,000	$36K	0.0%	-37.5%	0.023%
7/26/2024	Bank of New York Mellon Corp	308,997	$1.01M	0.0%	+63.6%	0.641%
7/18/2024	Assenagon Asset Management S.A.	140,205	$0.46M	0.0%	+99.9%	0.291%
5/17/2024	Athyrium Capital Management LP	1,256,411	$6.66M	9.1%	-29.9%	2.605%
5/15/2024	Lazard Asset Management LLC	49,466	$0.26M	0.0%	+5,129.0%	0.103%
5/14/2024	EntryPoint Capital LLC	61,991	$0.33M	0.3%	N/A	0.129%
5/13/2024	O Shaughnessy Asset Management LLC	77,081	$0.41M	0.0%	+127.7%	0.160%
5/10/2024	Acadian Asset Management LLC	1,956,513	$10.37M	0.0%	+2.0%	4.056%
5/10/2024	Vanguard Group Inc.	3,491,249	$18.50M	0.0%	-8.2%	7.237%
5/7/2024	Sei Investments Co.	289,677	$1.54M	0.0%	-0.8%	0.600%
5/7/2024	SG Americas Securities LLC	10,740	$57K	0.0%	N/A	0.022%
5/6/2024	LSV Asset Management	30,400	$0.16M	0.0%	-64.9%	0.063%
5/3/2024	GSA Capital Partners LLP	187,585	$0.99M	0.1%	-28.5%	0.389%

Data available starting January 2016

See Full Table

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company offers NERLYNX, an oral version of neratinib that is used to treat adult patients with early stage HER2-overexpressed/amplified breast cancer; and advanced or metastatic HER2-positive breast cancer when combined with capecitabine. It also develops alisertib, a small molecule inhibitor of aurora kinase A for the treatment of hormone receptor positive breast cancer, triple negative breast cancer, small cell lung cancer, and head and neck cancer. The company sells its products through specialty pharmacy and distributor networks. It has license agreements with Pfizer Inc. for the development, manufacture, and commercialization of neratinib (oral), neratinib (intravenous), PB357, and related compounds; and Takeda Pharmaceutical Company Limited for the research, development, and commercialization of alisertib, as well as sub-license agreements with Specialised Therapeutics Asia Pte Ltd., Medison Pharma Ltd., Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.

Today's Range

Now: $3.34

$3.33

$3.53

50 Day Range

MA: $3.09

$2.76

$3.74

52 Week Range

Now: $3.34

$2.23

$6.06

Volume

342,205 shs

Average Volume

455,697 shs

Market Capitalization

$165.70 million

P/E Ratio

6.96

Dividend Yield

N/A

Beta

1.33

Who are the company insiders with the largest holdings of Puma Biotechnology?: Puma Biotechnology's top insider shareholders include:
Alan H Auerbach (CEO)
Maximo F Nougues (CFO)
Jeffrey Jerome Ludwig (Insider)
Alvin F Wong (Insider)
Michael Patrick Miller (Director)
Troy Edward Wilson (Director)
Learn More about top insider investors at Puma Biotechnology.
Who are the major institutional investors of Puma Biotechnology?: Puma Biotechnology's top institutional investors include:
Acorn Capital Advisors LLC — 4.99%
Millennium Management LLC — 3.86%
Renaissance Technologies LLC — 3.58%
Eversept Partners LP — 2.03%
American Century Companies Inc. — 1.93%
Dimensional Fund Advisors LP — 1.76%
Learn More about top institutional investors of Puma Biotechnology stock.
Which major investors are selling Puma Biotechnology stock?: Within the last quarter, PBYI stock was sold by these institutional investors:
Millennium Management LLC
Eversept Partners LP
WINTON GROUP Ltd
Schonfeld Strategic Advisors LLC
State of Wyoming
Squarepoint Ops LLC
Renaissance Technologies LLC
Jane Street Group LLC
During the previous year, company insiders that have sold Puma Biotechnology company stock include:
Alan H Auerbach (CEO)
Maximo F Nougues (CFO)
Jeffrey Jerome Ludwig (Insider)
Alvin F Wong (Insider)
Michael Patrick Miller (Director)
Learn More investors selling Puma Biotechnology stock.
Which major investors are buying Puma Biotechnology stock?: During the previous quarter, PBYI stock was bought by institutional investors including:
Acorn Capital Advisors LLC
Kennedy Capital Management LLC
Dimensional Fund Advisors LP
D. E. Shaw & Co. Inc.
Two Sigma Investments LP
Connor Clark & Lunn Investment Management Ltd.
JPMorgan Chase & Co.
Marshall Wace LLP